Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BCLI - BrainStorm Cell Therapeutics stock falls amid FY21 results


BCLI - BrainStorm Cell Therapeutics stock falls amid FY21 results

Brainstorm Cell Therapeutics (BCLI -3.8%) stock declined following its FY21 results. Full year 2021 net loss amounted to -$24.46M, compared to net loss of -$31.8M in 2020. Research and development expenses decreased to $15.24M, compared to $22.33M in 2020. General and administrative expenses remained largely flat. For 2021 $9.3M, for 2020 ~$9.36M. As of Dec. 31, 2021, cash, cash equivalents, and short-term bank deposits were ~$22.1M, compared to $41.9M as of Dec. 31, 2020.

For further details see:

BrainStorm Cell Therapeutics stock falls amid FY21 results
Stock Information

Company Name: Brainstorm Cell Therapeutics Inc.
Stock Symbol: BCLI
Market: NASDAQ
Website: brainstorm-cell.com

Menu

BCLI BCLI Quote BCLI Short BCLI News BCLI Articles BCLI Message Board
Get BCLI Alerts

News, Short Squeeze, Breakout and More Instantly...